Cardiology Groups Push Back on Hydroxychloroquine, Azithromycin for COVID-19 Cardiology Groups Push Back on Hydroxychloroquine, Azithromycin for COVID-19

In a joint statement, leading cardiology associations urge caution with the use of these treatments in patients with COVID-19 and CVD.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news